Artikel dengan mandat akses publik - Chang LiuPelajari lebih lanjut
Tidak tersedia di mana pun: 1
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
B Mühlemann, SH Wilks, L Baracco, M Bekliz, JM Carreño, VM Corman, ...
Science translational medicine 16 (747), eadl1722, 2024
Mandat: Swiss National Science Foundation, Bill & Melinda Gates Foundation, Austrian …
Tersedia di suatu tempat: 65
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Y Peng, AJ Mentzer, G Liu, X Yao, Z Yin, D Dong, W Dejnirattisai, ...
Nature immunology 21 (11), 1336-1345, 2020
Mandat: Bill & Melinda Gates Foundation, US National Institutes of Health, National …
Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera
D Zhou, W Dejnirattisai, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (9), 2348-2361. e6, 2021
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
SARS-CoV-2 Omicron-B. 1.1. 529 leads to widespread escape from neutralizing antibody responses
W Dejnirattisai, J Huo, D Zhou, J Zahradník, P Supasa, C Liu, ...
Cell 185 (3), 467-484. e15, 2022
Mandat: Bill & Melinda Gates Foundation, US National Institutes of Health, UK …
Reduced neutralization of SARS-CoV-2 B. 1.617 by vaccine and convalescent serum
C Liu, HM Ginn, W Dejnirattisai, P Supasa, B Wang, A Tuekprakhon, ...
Cell 184 (16), 4220-4236. e13, 2021
Mandat: Bill & Melinda Gates Foundation, US National Institutes of Health, Cancer …
Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum
A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ...
Cell 185 (14), 2422-2433. e13, 2022
Mandat: US National Institutes of Health, UK Medical Research Council, National …
Antibody evasion by the P. 1 strain of SARS-CoV-2
W Dejnirattisai, D Zhou, P Supasa, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (11), 2939-2954. e9, 2021
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
Reduced neutralization of SARS-CoV-2 B. 1.1. 7 variant by convalescent and vaccine sera
P Supasa, D Zhou, W Dejnirattisai, C Liu, AJ Mentzer, HM Ginn, Y Zhao, ...
Cell 184 (8), 2201-2211. e7, 2021
Mandat: US National Institutes of Health, Cancer Research UK, UK Medical Research …
The antigenic anatomy of SARS-CoV-2 receptor binding domain
W Dejnirattisai, D Zhou, HM Ginn, HME Duyvesteyn, P Supasa, JB Case, ...
Cell, 2021
Mandat: US Department of Defense, US National Institutes of Health, Cancer Research …
Reduced neutralisation of SARS-CoV-2 omicron B. 1.1. 529 variant by post-immunisation serum
W Dejnirattisai, RH Shaw, P Supasa, C Liu, ASV Stuart, AJ Pollard, X Liu, ...
Lancet (London, England) 399 (10321), 234, 2021
Mandat: UK Medical Research Council, National Institute for Health Research, UK …
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease
Y Peng, SL Felce, D Dong, F Penkava, AJ Mentzer, X Yao, G Liu, Z Yin, ...
Nature immunology 23 (1), 50-61, 2022
Mandat: US National Institutes of Health, National Natural Science Foundation of …
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ...
Cell 185 (12), 2116-2131. e18, 2022
Mandat: US National Institutes of Health, UK Medical Research Council, National …
Convalescent plasma therapy for the treatment of patients with COVID‐19: assessment of methods available for antibody detection and their correlation with neutralising antibody …
H Harvala, ML Robb, N Watkins, S Ijaz, S Dicks, M Patel, P Supasa, ...
Transfusion Medicine 31 (3), 167-175, 2021
Mandat: UK Medical Research Council, National Institute for Health Research, UK …
Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020
CP Thompson, NE Grayson, RS Paton, JS Bolton, J Lourenco, ...
Eurosurveillance 25 (42), 2000685, 2020
Mandat: Cancer Research UK, UK Medical Research Council, National Institute for …
Identification of a small molecule that simultaneously suppresses virulence and antibiotic resistance of Pseudomonas aeruginosa
Q Guo, Y Wei, B Xia, Y Jin, C Liu, X Pan, J Shi, F Zhu, J Li, L Qian, X Liu, ...
Scientific reports 6 (1), 19141, 2016
Mandat: National Natural Science Foundation of China
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
C Liu, D Zhou, R Nutalai, HME Duyvesteyn, A Tuekprakhon, HM Ginn, ...
Cell Host & Microbe 30 (1), 53-68. e12, 2022
Mandat: US Department of Defense, US National Institutes of Health, UK Medical …
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75
J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ...
Cell reports 42 (1), 2023
Mandat: US National Institutes of Health, British Heart Foundation, UK Medical …
Pseudomonas aeruginosa Enolase Influences Bacterial Tolerance to Oxidative Stresses and Virulence
Y Weng, F Chen, Y Liu, Q Zhao, R Chen, X Pan, C Liu, Z Cheng, S Jin, ...
Frontiers in Microbiology 7, 1999, 2016
Mandat: National Natural Science Foundation of China
Polynucleotide Phosphorylase Regulates Multiple Virulence Factors and the Stabilities of Small RNAs RsmY/Z in Pseudomonas aeruginosa
R Chen, Y Weng, F Zhu, Y Jin, C Liu, X Pan, B Xia, Z Cheng, S Jin, W Wu
Frontiers in microbiology 7, 247, 2016
Mandat: National Natural Science Foundation of China
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimens
SC Moore, B Kronsteiner, S Longet, S Adele, AS Deeks, C Liu, ...
Med 4 (3), 191-215. e9, 2023
Mandat: US National Institutes of Health, British Heart Foundation, UK Medical …
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer